欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/V/0438/001
药品名称
RILEXINE DC
活性成分
cefalexin 375.0 mg/dose
剂型
Intramammary suspension
上市许可持有人
VIRBAC
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
Spain (ES)
Slovenia (SI)
Portugal (PT)
Croatia (HR)
Italy (IT)
United Kingdom (Northern Ireland) (XI)
Finland (FI)
Poland (PL)
Latvia (LV)
Lithuania (LT)
Germany (DE)
Estonia (EE)
Denmark (DK)
Hungary (HU)
Belgium (BE)
Rilexine DC
Bulgaria (BG)
Netherlands (NL)
Czechia (CZ)
Ireland (IE)
Romania (RO)
Austria (AT)
Slovakia (SK)
许可日期
2022/02/09
最近更新日期
2022/05/09
药物ATC编码
QJ51DB01 cefalexin
申请类型
TypeLevel1:
food
TypeLevel2:
Pharmaceutical
TypeLevel3:
Other Generic application Art 13.3 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
15247 D205 SPC_pl_Rilexine DC
Date of last change:2022/06/02
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase